Role of caveolin 1 in AT1a receptor-mediated uptake of angiotensin II in the proximal tubule of the kidney

被引:20
作者
Li, Xiao C.
Gu, Victor
Miguel-Qin, Elise
Zhuo, Jia L.
机构
[1] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol,Div Nephrol, Lab Receptor & Signal Transduct,Dept Med, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA
关键词
angiotensin II; angiotensin II type 1a receptor; blood pressure; caveolin; 1; kidney; proximal tubule; signal transduction; BLOOD-PRESSURE; IN-VIVO; ANG-II; VASCULAR RELAXATION; NHE-3; EXPRESSION; TYPE-1; RECEPTOR; HYPERTENSION; MECHANISMS; SODIUM; CELLS;
D O I
10.1152/ajprenal.00199.2014
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Caveolin 1 (CAV-1) functions not only as a constitutive scaffolding protein of caveolae but also as a vesicular transporter and signaling regulator. In the present study, we tested the hypothesis that CAV-1 knockout (CAV-1 KO) inhibits ANG II type 1 [AT(1) (AT(1a))] receptor-mediated uptake of ANG II in the proximal tubule and attenuates blood pressure responses in ANG II-induced hypertension. To determine the role of CAV-1 in mediating the uptake of FITC-labeled ANG II, wild-type (WT) mouse proximal convoluted tubule cells were transfected with CAV-1 small interfering (si) RNA for 48 h before AT(1) receptor-mediated uptake of FITC-labeled ANG II was studied. CAV-1 siRNA knocked down CAV-1 expression by >90% (P < 0.01) and inhibited FITC-labeled ANG II uptake by >50% (P < 0.01). Moreover, CAV-1 siRNA attenuated ANG II-induced activation of MAPK ERK1/2 and Na+/H+ exchanger 3 expression, respectively (P < 0.01). To determine whether CAV-1 regulates ANG II uptake in the proximal tubule, Alexa 488-labeled ANG II was infused into anesthetized WT and CAV-1 KO mice for 60 min (20 ng/min iv). Imaging analysis revealed that Alexa 488-labeled ANG II uptake was decreased by >50% in CAV-1 KO mice (P < 0.01). Furthermore, Val(5)-ANG II was infused into WT and CAV-1 KO mice for 2 wk (1.5 mg.kg(-1).day(-1) ip). Basal systolic pressure was higher, whereas blood pressure and renal excretory and signaling responses to ANG II were attenuated, in CAV-1 KO mice (P < 0.01). We concluded that CAV-1 plays an important role in AT(1) receptor-mediated uptake of ANG II in the proximal tubule and modulates blood pressure and renal responses to ANG II.
引用
收藏
页码:F949 / F961
页数:13
相关论文
共 50 条
[1]   RECEPTOR-BINDING AND INTERNALIZATION OF A UNIQUE BIOLOGICALLY-ACTIVE ANGIOTENSIN-II COLLOIDAL GOLD CONJUGATE - MORPHOLOGICAL ANALYSIS OF ANGIOTENSIN-II PROCESSING IN ISOLATED VASCULAR STRIPS [J].
ANDERSON, KM ;
PEACH, MJ .
JOURNAL OF VASCULAR RESEARCH, 1994, 31 (01) :10-17
[2]   Basolateral distribution of caveolin-1 in the kidney:: Absence from H+-ATPase-coated endocytic vesicles in intercalated cells [J].
Breton, S ;
Lisanti, MP ;
Tyszkowski, R ;
McLaughlin, M ;
Brown, D .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1998, 46 (02) :205-214
[3]   Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis [J].
Cao, GW ;
Yang, GA ;
Timme, TL ;
Saika, T ;
Truong, LD ;
Satoh, T ;
Goltsov, A ;
Park, SH ;
Men, T ;
Kusaka, N ;
Tian, WH ;
Ren, CZ ;
Wang, HY ;
Kadmon, D ;
Cai, WW ;
Chinault, AC ;
Boone, TB ;
Bradley, A ;
Thompson, TC .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1241-1248
[4]   Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice [J].
Chuengsamarn, Somlak ;
Garza, Amanda E. ;
Krug, Alexander W. ;
Romero, Jose R. ;
Adler, Gail K. ;
Williams, Gordon H. ;
Pojoga, Luminita H. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (02) :275-281
[5]   Role of caveolae and caveolins in health and disease [J].
Cohen, AW ;
Hnasko, R ;
Schubert, W ;
Lisanti, MP .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1341-1379
[6]   Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts [J].
Cohen, AW ;
Park, DS ;
Woodman, SE ;
Williams, TM ;
Chandra, M ;
Shirani, J ;
De Souza, AP ;
Kitsis, RN ;
Russell, RG ;
Weiss, LM ;
Tang, BY ;
Jelicks, LA ;
Factor, SM ;
Shtutin, V ;
Tanowitz, HB ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02) :C457-C474
[7]   Caveolae, caveolin, and cavins: Potential targets for the treatment of cardiac disease [J].
Das, Manika ;
Das, Dipak K. .
ANNALS OF MEDICINE, 2012, 44 (06) :530-541
[8]   Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis [J].
Desjardins, Fanny ;
Lobysheva, Irina ;
Pelat, Michel ;
Gallez, Bernard ;
Feron, Olivier ;
Dessy, Chantal ;
Balligand, Jean-Luc .
CARDIOVASCULAR RESEARCH, 2008, 79 (03) :527-536
[9]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452
[10]  
Ferguson SSG, 2001, PHARMACOL REV, V53, P1